Biontech eps
WebBioNTech SE ADR balance sheet, income statement, cash flow, earnings & estimates, ratio and margins. View BNTX financial statements in full. Dow Jones, a News Corp company … WebSee BioNTech SE (BNTX) stock analyst estimates, including earnings and revenue, EPS, upgrades and downgrades.
Biontech eps
Did you know?
WebEPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that … WebApr 11, 2024 · BioNTech SE (NASDAQ:BNTX) Analysts Just Slashed This Year's Estimates Mar 29 Full year 2024 earnings: EPS and revenues exceed analyst expectations Mar 29 These 4 Measures Indicate That BioNTech (NASDAQ:BNTX) Is Using Debt Safely Mar 05 A Look At The Fair Value Of BioNTech SE (NASDAQ:BNTX) Feb 18
WebApr 6, 2024 · BioNTech SE (BNTX) latest earnings report: revenue, EPS, surprise, history, news and analysis. WebApr 10, 2024 · What is the target price for BioNTech (BNTX) stock? A The latest price target for BioNTech ( NASDAQ: BNTX) was reported by UBS on Friday, March 31, 2024. The analyst firm set a price target for...
WebSecond-Quarter 2024 Reported Diluted EPS(2) of $0.98, Adjusted Diluted EPS(3) of $1.07 ... the Pfizer-BioNTech SE (BioNTech) COVID-19 vaccine, as well as its business excluding BNT162b2(1). Additionally, Pfizer published this morning on its website the second-quarter 2024 earnings presentation and WebEPS for BioNTech (BNTX) EPS in 2024 (TTM): $46.72. According to BioNTech's latest financial reports the company's current EPS (TTM) is $46.72. In 2024 the company made …
WebMar 27, 2024 · BioNTech press release (NASDAQ:BNTX): Q4 GAAP EPS of €9.26 beats by €1.51.; Revenue of €4.28B (-22.6% Y/Y) beats by €420M. Expanded and advanced …
csrd reporting softwareWebRevenue and Earnings Per Share (EPS) are the heart of the fundamental analysis of a company's worth. The Revenue and EPS Summary provides the Revenue, EPS and Dividends of a company by year... ean scannerWebMar 29, 2024 · BioNTech (NASDAQ:BNTX – Get Rating) announced its quarterly earnings results on Monday.The company reported $9.26 earnings per share (EPS) for the quarter, beating the consensus estimate of $8.04 by $1.22, MarketWatch Earnings reports. BioNTech had a return on equity of 66.45% and a net margin of 55.72%. csrd scopingWebApr 13, 2024 · Die Zahlen des am 31.12.2024 abgelaufenen Quartals präsentierte BioNTech (ADRs) am 27.03.2024. Das EPS wurde auf 9,26 EUR beziffert. Ein Jahr … csrd scoping metricsWebApr 9, 2024 · BioNTech last announced its quarterly earnings data on March 27th, 2024. The reported $9.26 EPS for the quarter, beating the consensus estimate of $8.04 by … csrd sector specificWebBioNTech SE EPS for the quarter ending December 31, 2024 was $9.92, a 29.42% decline year-over-year. BioNTech SE EPS for the twelve months ending December 31, 2024 … ean scoreWebMar 29, 2024 · Analysts estimate that BioNTech will report an earnings per share (EPS) of $8.19. BioNTech (NASDAQ:BNTX) is set to give its latest quarterly earnings report on Wednesday, 2024-03-30. ean scott